Clinical Trials in Georgia

Showing 2561-2580 of 16,324 trials

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

NCT06768671

This is a study to evaluate the pharmacokinetic (PK) and safety of sonelokimab in adolescent patients with HS.

MoonLake Immunotherapeutics AG35 participantsStarted Dec 2024

North Little Rock, Arkansas, United States • Stanford, California, United States • Washington D.C., District of Columbia, United States +15 more locations

Active Not RecruitingPhase 163 miles

A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV

NCT06919016

This is a phase 1, first-in-human (FIH) trial for two vaccines, DV700P-RNA and DV701B1.1-RNA. This means it is the first time these study products are being tested in people. The purpose of this study is to see if the study products are safe, if people are able to take them without becoming too uncomfortable, and how a person's immune system responds to them (a person's immune system protects them from infections and disease). Forty-five volunteers without HIV and in overall good health, aged 18 to 55 years, will be enrolled and be in this study for about 16 months (about 12 visits), Study procedures will include blood draws, injections, and the collection of white blood cells and cells from their lymph nodes.

HIV-1-infection

National Institute of Allergy and Infectious Diseases (NIAID)45 participantsStarted Aug 2025

Birmingham, Alabama, United States • Decatur, Georgia, United States • Boston, Massachusetts, United States +5 more locations

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV

Find Trials by Condition in Georgia

BHV-7000 Open-Label Extension Bipolar Mania Study

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study

Nirogacestat in Ovarian Granulosa Cell Tumors

Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation

A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors